Echinacea and truth in labeling.
Open Access
- 24 March 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (6) , 699-704
- https://doi.org/10.1001/archinte.163.6.699
Abstract
SALES OF HERBS and phytomedicines in the United States have exploded in recent years. Americans spent $5.1 billion in 1997 on herbal medicines, nearly a 4-fold increase since 1990.1 Sales of Echinacea represent 10% of the total US market in herbal medicines.2 Most herbal products are used to treat minor conditions and illnesses in much the same manner as conventional Food and Drug Administration (FDA)–approved over-the-counter medicines. Herbal medicines are not subject to FDA evaluation and approval; however, there are no assurances as to whether an herbal medicine works, what portion of the herb has the effect, whether that portion is present in an herbal medicine in any measurable quantity, or that the label reflects the content.This publication has 7 references indexed in Scilit:
- Echinacea Standardization: Analytical Methods for Phenolic Compounds and Typical Levels in Medicinal SpeciesJournal of Agricultural and Food Chemistry, 2001
- Enzymatic Degradation of Cichoric Acid in Echinacea purpurea PreparationsJournal of Natural Products, 2000
- Alkylamide and Cichoric Acid Levels inEchinacea purpureaTissues During Plant GrowthJournal of Herbs, Spices & Medicinal Plants, 2000
- Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national surveyComplementary Therapies in Medicine, 1999
- Immunomodulation with echinacea — a systematic review of controlled clinical trialsPhytomedicine, 1994
- Lead poisoning due to hai ge fen. The porphyrin content of individual erythrocytesPublished by American Medical Association (AMA) ,1994
- TLC and HPLC Analysis of Alkamides inEchinaceaDrugs1,2Planta Medica, 1989